EP2717827A1 - Vorrichtung zur verbindung zwischen einem empfänger und einem gehäuse und verfahren zur montage und verwendung einer solchen vorrichtung - Google Patents

Vorrichtung zur verbindung zwischen einem empfänger und einem gehäuse und verfahren zur montage und verwendung einer solchen vorrichtung

Info

Publication number
EP2717827A1
EP2717827A1 EP12729060.9A EP12729060A EP2717827A1 EP 2717827 A1 EP2717827 A1 EP 2717827A1 EP 12729060 A EP12729060 A EP 12729060A EP 2717827 A1 EP2717827 A1 EP 2717827A1
Authority
EP
European Patent Office
Prior art keywords
container
needle
base
bore
sleeve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP12729060.9A
Other languages
English (en)
French (fr)
Other versions
EP2717827B1 (de
Inventor
Antoine Aneas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocorp Production SAS
Original Assignee
Biocorp Recherche et Developpement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocorp Recherche et Developpement filed Critical Biocorp Recherche et Developpement
Priority to PL12729060T priority Critical patent/PL2717827T3/pl
Publication of EP2717827A1 publication Critical patent/EP2717827A1/de
Application granted granted Critical
Publication of EP2717827B1 publication Critical patent/EP2717827B1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2089Containers or vials which are to be joined to each other in order to mix their contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096Combination of a vial and a syringe for transferring or mixing their contents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003Filling medical containers such as ampoules, vials, syringes or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006Piercing means
    • A61J1/201Piercing means having one piercing end
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048Connecting means
    • A61J1/2055Connecting means having gripping means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048Connecting means
    • A61J1/2065Connecting means having aligning and guiding means
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00Metal working
    • Y10T29/49Method of mechanical manufacture
    • Y10T29/49826Assembling or joining
    • Y10T29/49863Assembling or joining with prestressing of part
    • Y10T29/4987Elastic joining of parts

Definitions

  • the invention relates to a connection device between a container provided with a neck closed by a pierceable stopper and a container intended to be equipped with a needle, such a container may, for example, be a syringe.
  • the invention also relates to a method of assembling such a connection device and to a method of filling a container intended to be equipped with a needle, in which such a connection device is used.
  • FR A 2,717,086 provides for connecting a vial to a syringe already equipped with a needle by using a guide piece which comprises a cylindrical body.
  • a fastener is part of a proximal end of a cylindrical sheath whose distal end is guided by a sleeve and forms a tip for perforating a workpiece mounted in an end portion of the cylindrical body.
  • This distal end is not integral with the sleeve but the fastener, so that the perforation of the cap can be obtained only by the introduction of the syringe with its needle inside the connection device. This material does not allow access to the interior volume of the bottle as the syringe is not in place.
  • a portion of elastic material ensures the seal between the end of the syringe and the fastener, without coming into contact with the needle.
  • the dead volume of this material extends to the level of the nose of the syringe, which induces significant product losses.
  • GB 2 446 778 discloses an adapter which is intended to cooperate with a standard syringe provided with a needle, which is not compatible with the use of a syringe devoid of needle.
  • the risks of leakage around the needle of the syringe are important especially when a set of a bottle of an adapter and a needle is disposed in reverse configuration to drain the contents of the bottle in the needle.
  • the invention relates to a connection device between a container provided with a neck closed by a pierceable stopper and a container intended to be equipped with a needle, this device comprising a base provided with mounting means on the container. which defines a central bore and on which the container can be mounted.
  • a needle belonging to a subassembly engaged in the central bore of the base part of the connection device and intended to be mounted on the container, is disposed in the central bore, according to a direction parallel to a longitudinal axis of this bore, while a sealing sleeve is disposed in the central bore, around the needle and in contact therewith, the base being integral and comprising a perforating member plug extending from an intermediate wall of the base, opposite the central bore, parallel to its central axis and to a distal end, while the perforating member of the The plug is hollow and its internal volume is in communication with the central bore and with a volume radially surrounding the distal end of the perforating member.
  • connection device of the invention can take place by means of translational movements, without requiring rotation or complex movement, which is quite intuitive for a user.
  • the device of the invention is compact and effectively protects the needle before use.
  • the device of the invention is compatible with the use of a syringe devoid of needle since the subset to which the needle belongs is engaged in the central bore of the base.
  • the perforating member may be provided to perforate the cap of the container due to the only establishment of this base on the neck of the container.
  • the structure of the device of the invention is furthermore simple, which makes it possible to control its cost price and its manufacturing time. According to advantageous but non-mandatory aspects of the invention, such a device may incorporate one or more of the following features, taken in any technically permissible combination:
  • the internal volume of the perforating member forms a partial receiving housing of the needle.
  • the free end of the part of the needle received in the internal volume of the perforating member is offset, in a direction parallel to the longitudinal axis of the bore, by at least 2 mm relative to the distal end of the perforating member.
  • the minimum unstressed inner diameter of the sleeve is smaller than the outer diameter of the needle.
  • the base and a fixed end of the needle are provided with complementary relief blocking the needle in a translation movement parallel to the longitudinal axis of the bore, in the direction of the perforating member.
  • the sleeve is supported, opposite the tip, against the bottom of the bore while, when the tip is blocked against the base by cooperation complementary reliefs, it exerts on the sleeve a force of axial compression and that the sleeve is provided to expand radially under the effect of such a compressive force.
  • the sleeve is cylindrical outer shape with a circular base, on one part, and frustoconical shape, on another part.
  • the perforating member is provided to perforate the cap of the container due to the sole mounting of the base on the container, without interaction with the container.
  • the dead volume of the device extends in the internal volume of the perforating member, in the sleeve to a narrowed area of the sleeve in contact with the needle and around the perforating member.
  • the dead volume of the device is less than 25 mm 3 .
  • the subassembly is provided with removable hooking means on the container.
  • the invention also relates to a method of assembling a device as mentioned above which comprises the steps of:
  • the invention relates to a method of filling a container intended to be equipped with a needle with a product contained in a container provided with a neck closed by a pierceable stopper.
  • a connection device as mentioned above is used and steps of:
  • the mounting means are elastically deformed and are hooked under the neck of the receptacle, keeping the perforating member in a position where it puts the volume in communication with one another. internal of the container and the internal volume of a part of the subassembly in place in the central bore of the base.
  • Figure 1 is an exploded perspective view and in axial section, over a quarter of its circumference, a connection device according to the invention
  • Figure 2 is an axial section of the device of Figure 1 above a bottle whose neck is closed by a pierceable stopper;
  • Figure 3 is a section similar to Figure 2 when the connecting device is mounted on the bottle;
  • connection device is an exploded perspective view of the connection device, at another angle and in axial section on its half-circumference;
  • Figures 5 to 8 are side views showing steps of a method of assembling the device of Figures 1 to 4 and
  • Figures 9 to 13 show steps of a drug reconstitution process, in which a syringe is filled with a product contained in a vial, using the device of Figures 1 to 4.
  • connection device 10 shown in Figures 1 to 4 comprises a base 20 monobloc and made of molded synthetic material, for example polycarbonate or ABS.
  • This base 20 is provided with an annular portion 21 from which extend four tabs 22 elastically deformable and whose geometry allows their snapping around the outer collar 122 of the neck 120 of a glass vial 1 10.
  • the tabs 22 define between them a volume V22 receiving the neck 120 when the device 10 is in place on the bottle 1 10, as shown in Figure 3.
  • an inner beak 24 of each tab 22 abuts against a lower flank 134 of a cap 130 which surrounds the flange 122.
  • This flank 134 is itself in abutment against a surface 124 of the flange 122 which is directed towards the bottom 1 12 of the flask 10.
  • the base 20 is provided with a central bore 26 whose X26 longitudinal axis is noted.
  • the axis X26 constitutes a longitudinal and central axis for the base 20.
  • Four stiffening ribs 252 are formed outside the tubular portion 25 at the center of which is formed the bore 26.
  • the ribs 252 extend between the tubular portion 25 and the annular portion 21.
  • 23 is the surface of the portion 21 opposite the ribs 252.
  • the surface 23 is perpendicular to the axis X26 and the tabs 22 extend parallel to the axis X26, from a skirt 27 which surrounds this surface.
  • the volume V22 extends to the level of the surface 23 and is surrounded, radially with respect to the axis X26, by the skirt 27 in the vicinity of the surface 23.
  • the portion of the volume V22 closest to the surface 23 surround the flange 122 and the cap 130 in the mounted configuration of the base 20 on the bottle 1 10.
  • the end of the portion 25 opposite the portion 21 is bordered by an outer flange 254.
  • the inner spouts 24 of the tabs 22 are each provided with a surface 242 facing away from the bore 26.
  • the surfaces 242 are frustoconical and divergent with respect to the axis X26 away from the bore 26. This geometry of the surfaces 242 facilitates the elastic deformation of the tabs 22 during the introduction of the base 20 on the neck 120 of the bottle 1 10, by an axial translation movement.
  • a hollow punch 28 extends along the axis X26, in the volume V22 and from the center of the surface 23.
  • the punch 28 is intended to perforate a plug 128 of elastomer which closes the neck 120. In this sense the punch 28 constitutes a perforating member of the plug 128.
  • the plug 128 is immobilized in the neck 120 thanks to the cap 130 which is made of aluminum or plastic.
  • V28 denotes the internal volume of the punch 28, this inner volume being in the form of a bore centered on the axis X26.
  • An opening 286 is provided on one side of the punch 28, near the end 282. This opening communicates the volume V28 with the volume V22 which surrounds the end 282, radially with respect to the axis X26.
  • the device 10 also comprises a one-piece sealing sleeve 40 made of a synthetic or natural flexible material, such as an elastomer.
  • the sleeve 40 is made of injection moldable Santoprene.
  • X40 is noted the longitudinal axis of the sleeve 40 and V40 its internal volume which is centered on the axis X40 and symmetrical with respect to this axis.
  • the diameter of the volume V40 is variable over the length of the sleeve 40. More specifically, the sleeve 40 comprises a narrowed zone 42 where its internal diameter has a minimum value d40 when the sleeve 40 is not constrained by external forces.
  • the outer surface of the sleeve 40 comprises a portion 44 which is cylindrical with a circular cross-section and centered on the axis X40, and a portion 46 which is frustoconical, centered on the axis X40 and convergent towards this axis in a direction away from Portion 44.
  • the bore 26 comprises two portions 267 and 268 which are respectively cylindrical and frustoconical and convergent towards the bottom 62.
  • the axial lengths of the portions 267 and 268 are respectively the same as those of the portions 44 and 46 of the sleeve 40.
  • the device 10 further comprises a subset 60 formed of a hollow needle 62 and a tip 64 mounted around the proximal end 624 of the needle 62.
  • the subassembly 60 The subassembly 60 is engaged in the bore 26 where it is waiting for connection with a syringe, as explained below.
  • the tip 60 is provided to be mounted reversibly on a syringe. It can be a standard product of the trade, whose cost price is well controlled.
  • the needle 62 is metal
  • the tip 64 is plastic, for example polypropylene.
  • the tip 64 is provided with a flange 642 for attachment to the end of a syringe 210, such as those conventionally used for the reconstitution and injection of drugs.
  • the interior volume V64 of the tip 64 is in communication with the central channel 626 of the needle 62.
  • the elements 62 and 64 can be secured by any known technique, in particular by overmolding or gluing.
  • X60 is a longitudinal axis of the subassembly 60.
  • the elements 62 and 64 are aligned and centered on the axis X60.
  • the end piece 64 is provided with four fins 644 which extend outwardly from the endpiece 64, radially with respect to the axis X60.
  • the surface of the base 20 which defines the bore 26 is provided with reliefs 263 between which are defined slideways 264 for receiving the fins 644 when the endpiece 64 is engaged in the bore 26, as explained herein. -after.
  • the cooperation of the fins 644 and slideways 264 provides an antirotation function of the subassembly 60 relative to the base 20 when the endpiece 64 and engaged in the bore 26.
  • the end piece 64 is also provided with an outer shoulder 646 which extends between the fins 644 and bears against a surface 266 of each relief 263 which is opposite the bottom 262. The cooperation of the shoulder 646 and the 266 surfaces limits the depression of the tip 64, and therefore the needle 62, in the bore 26, towards the volume V22.
  • the axes X26, X40 and X60 are merged and the sealing sleeve 40 in place in the bore 26 rests against the bottom 262 by its end surface 49 opposite the portion 48.
  • the shoulder 646 rests on the surfaces 266 and the fins 644 exert on the sleeve 40 a force E1 bearing the sleeve 40 against the bottom 262.
  • the bottom 262 then exerts a reaction force E2 on the sleeve 40.
  • the sleeve 40 is compressed between the end surface 644A of the fins 644 and the bottom 642.
  • This compression of the sleeve 40 has the effect of expanding it radially with respect to the X26 and X40 axes when merged, which firmly portions 44 and 46 of its outer surface against the surface defining the bore 26 inside the base 20, respectively at its portions 267 and 268.
  • the seal between the elements 20 and 40 is thus ensured persistent.
  • This seal is obtained thanks to the elastically deformable character, radially with respect to the axis X40, of the sleeve 40.
  • the needle 62 extends parallel to the axis X26. In practice, it extends along the axis X26 and the distal end 622 of the needle 22 is engaged in the volume V28, without contact with the inner surface of the punch 28. The punch 28 thus mechanically protects this distal end 622 , without risk of pollution.
  • the distal end 622 of the needle 62 is shifted along the axes X26 and X60 together, a length fo. relative to the distal end 282 of the punch 28.
  • the length fo. is greater than 2 mm, preferably greater than 3 mm, which reduces the dead volume around the needle 62 when the bottle 1 equipped with the device 10 is returned to the position of Figure 12.
  • the punch 28 has perforated the plug 128 due to the engagement of the tabs 22 under the flange 122, so that the volume V28 communicates with the internal volume V1 of the vial 10, through the opening 286. Since the distal end 622 of the needle 62 is disposed in this volume V28, the central channel 626 of the needle 62 thus communicates with the volume V1 10, through the volume V28, the opening 286 and the volume V22. Given its one-piece nature with the rest of the base 20 and in particular with the annular portion 21, the punch 28 is caused to perforate the plug 128 simply by mounting the base 20 on the container 10, without interaction with a syringe or other member external to the device 10.
  • the device 10 makes it possible to put the channel 626 in communication with the volume V1 10, while protecting the distal end 622 of the needle 62 which is mounted on the base 20, within the device 10, prior to implementation.
  • place this device on the bottle D62 denotes the outer diameter of the needle 62, this diameter being constant over the length of the needle.
  • the diameter d40 is chosen smaller than the diameter D62. In practice, the difference in these diameters can be between 5% and 25% of the diameter. This ensures an effective sealing between the sleeve 40 and the needle 62, at the zone 42. This also ensures, when removing the subassembly 60 relative to the base 20 as explained below, the friction wiping the outer surface of the needle 62, at its portion received in the volume V28.
  • the dead volume of the assembly formed by the device 10 and the bottle 1 10 comprises an interior volume portion V28 of the punch 28 and a portion V'40 of the volume. inside the sleeve 40 which extends between the volume V28 the narrowed area 42 of the sleeve 40 which is in contact with the needle 62.
  • This dead volume also comprises a portion V128 of the internal volume of the plug 128 which extends between the bottom of this plug and the opening 286.
  • This dead volume is shown in gray in Figure 3. It is substantially less important than in known materials, in particular because it does not extend substantially above the punch 28 since the narrowed zone 42 is close to the lower end of the sleeve 40.
  • This dead volume consisting of the volumes V28, V'40 and V128 has a value less than 25 mm 3 , in practice less than 22 mm 3 (cubic millimeters).
  • FIGS. 5 to 8 A method of assembling the device 10 is shown in FIGS. 5 to 8.
  • a tube 310 secured to a support 320 is used, as well as a plate 330 movable in translation relative to the support 320 and to the tube 310.
  • the tube 310 is chosen so that its outer diameter D310 is compatible with its introduction into the sleeve 40, by means of an elastic deformation thereof.
  • the inside diameter d310 of the tube 310 is chosen strictly greater than the diameter d62.
  • the subassembly 60 is positioned relative to the sleeve 40 by aligning the axis X60 with the central axis X310 of the tube 310, then the needle 62 is engaged in the tube 310, which is possible considering the difference between diameters D62 and d310.
  • This operation is represented by the arrow F2 in FIG. 6. It takes place without contact between the sleeve 40 and the needle 62.
  • the plate 330 is spaced apart from the support 320, in translation along the axis X310 and the axis X60, as represented by the arrow F3, which has the effect of extracting the tube 310 of the sleeve 40 then in place around the needle 62.
  • the elements 60 and 40 are pre-assembled and the distal end 622 of the needle 62 protrudes from the sleeve 40 without having been in direct contact with it, thus without risk of pollution of this end 622 by the material constituting the sleeve 40.
  • the base 20 is reported around the elements 60 and 40 pre-assembled, as shown by the arrow F4. During this movement, the X26, X40 and X60 axes are aligned. The distal end 622 of the needle 62 is introduced into the interior volume V28 without contact with the base 20.
  • the minimum inside diameter d28 of the punch 28 is greater than the diameter D62.
  • the diameter d28 may be between two and four times greater than the diameter D62.
  • the device 10 Before use, the device 10, which is compact, can be stored in a blister 400, as shown in FIG. 9.
  • the blister 400 is open and the device 10 is mounted on the neck 120 of the bottle 1 10 by placing it on this neck and then exerting a thrust towards the bottom 1 12 in the direction of the arrow F5 in Figure 2.
  • This allows the device 10 to pass from the configuration of the FIG. 2 to that of FIGS. 3 and 10, with elastic deformation of the tabs 22. This induces the perforation of the plug 128 by the punch 28.
  • a luer or luer-lock type lock can be used. Alternatively, other types of locks may be considered.
  • the resilient and tight support of the sleeve 40 around the needle 62 ensures that the contents of the bottle 1 10 do not leak in the volume V40, below the portion 42.
  • This extraction movement induces a cleaning of the distal portion of the needle 62 by the sleeve 40, as explained above.
  • the device 10 of the invention is particularly simple and intuitive to use, exerting only axial forces, except for the connection of the syringe 210 on the tip 64, and that it comprises three main parts, namely the base 20 and the sleeve 40 which are integral and the subassembly 60 consists of two parts.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Closures For Containers (AREA)
EP12729060.9A 2011-06-06 2012-06-05 Vorrichtung zur Verbindung zwischen einem Empfänger und einem Gehäuse und Verfahren zur Montage und Verwendung einer solchen Vorrichtung Active EP2717827B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL12729060T PL2717827T3 (pl) 2011-06-06 2012-06-05 Urządzenie łączące pomiędzy naczyniem oraz pojemnikiem, sposób składania oraz stosowania takiego urządzenia

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1154884A FR2975896B1 (fr) 2011-06-06 2011-06-06 Dispositif de connexion entre un recipient et un contenant, procede d'assemblage et d'utilisation d'un tel dispositif
PCT/EP2012/060591 WO2012168235A1 (fr) 2011-06-06 2012-06-05 Dispositif de connexion entre un récipient et un contenant, procédé d'assemblage et d'utilisation d'un tel dispositif

Publications (2)

Publication Number Publication Date
EP2717827A1 true EP2717827A1 (de) 2014-04-16
EP2717827B1 EP2717827B1 (de) 2015-07-29

Family

ID=46331260

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12729060.9A Active EP2717827B1 (de) 2011-06-06 2012-06-05 Vorrichtung zur Verbindung zwischen einem Empfänger und einem Gehäuse und Verfahren zur Montage und Verwendung einer solchen Vorrichtung

Country Status (13)

Country Link
US (1) US8985162B2 (de)
EP (1) EP2717827B1 (de)
JP (1) JP5981535B2 (de)
CN (1) CN103619306B (de)
AU (1) AU2012266433B2 (de)
BR (1) BR112013031087B1 (de)
CA (1) CA2837816C (de)
ES (1) ES2545631T3 (de)
FR (1) FR2975896B1 (de)
PL (1) PL2717827T3 (de)
PT (1) PT2717827E (de)
RU (1) RU2602743C2 (de)
WO (1) WO2012168235A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL201323A0 (en) 2009-10-01 2010-05-31 Medimop Medical Projects Ltd Fluid transfer device for assembling a vial with pre-attached female connector
IL202070A0 (en) 2009-11-12 2010-06-16 Medimop Medical Projects Ltd Inline liquid drug medical device
FR2967655B1 (fr) * 2010-11-24 2014-03-14 Biocorp Rech Et Dev Dispositif de bouchage d'un recipient, recipient equipe d'un tel dispositif et procede de fermeture d'un lot de tels recipients
USD737436S1 (en) 2012-02-13 2015-08-25 Medimop Medical Projects Ltd. Liquid drug reconstitution assembly
IL219065A0 (en) 2012-04-05 2012-07-31 Medimop Medical Projects Ltd Fluid transfer device with manual operated cartridge release arrangement
IL221635A0 (en) 2012-08-26 2012-12-31 Medimop Medical Projects Ltd Drug vial mixing and transfer device for use with iv bag and drug vial
IL221634A0 (en) 2012-08-26 2012-12-31 Medimop Medical Projects Ltd Universal drug vial adapter
JP5868555B2 (ja) 2012-09-13 2016-02-24 メディモップ・メディカル・プロジェクツ・リミテッド 入れ子式雌薬瓶アダプタ
USD734868S1 (en) 2012-11-27 2015-07-21 Medimop Medical Projects Ltd. Drug vial adapter with downwardly depending stopper
US9597260B2 (en) 2013-03-15 2017-03-21 Becton Dickinson and Company Ltd. System for closed transfer of fluids
IL225734A0 (en) 2013-04-14 2013-09-30 Medimop Medical Projects Ltd A ready-to-use medicine vial device including a medicine vial closure, and a medicine vial closure for it
BR112015027555B1 (pt) 2013-05-10 2022-02-01 Medimop Medical Projects Ltd Dispositivo médico para uso com uma seringa sem agulha, um frasco e um veículo líquido para preencher a seringa sem agulha com uma solução de injeção para injeção em um paciente
USD765837S1 (en) 2013-08-07 2016-09-06 Medimop Medical Projects Ltd. Liquid transfer device with integral vial adapter
USD767124S1 (en) 2013-08-07 2016-09-20 Medimop Medical Projects Ltd. Liquid transfer device with integral vial adapter
KR200486088Y1 (ko) 2013-08-07 2018-04-02 메디모프 메디컬 프로젝트스 리미티드. 주입 액체 용기와 함께 사용하기 위한 액체 전달 장치
US9636278B2 (en) 2013-11-06 2017-05-02 Becton Dickinson and Company Limited System for closed transfer of fluids with a locking member
CA2929473C (en) 2013-11-06 2019-06-04 Becton Dickinson and Company Limited Medical connector having locking engagement
CN105792793B (zh) 2013-11-06 2020-08-14 贝克顿·迪金森有限公司 带连接器的液体密封转移系统
EP3065812B1 (de) 2013-11-06 2020-01-01 Becton Dickinson and Company Limited Verbindungsvorrichtung für eine medizinische vorrichtung
CA2945533C (en) 2014-04-16 2018-10-16 Becton Dickinson and Company Limited Fluid transfer device with axially and rotationally movable portion
US10441507B2 (en) 2014-04-21 2019-10-15 Becton Dickinson and Company Limited Syringe adapter with disconnection feedback mechanism
WO2015164333A1 (en) 2014-04-21 2015-10-29 Becton Dickinson and Company Limited System for closed transfer of fluids
WO2015164385A1 (en) 2014-04-21 2015-10-29 Becton Dickinson and Company Limited System with adapter for closed transfer of fluids
CA2946563C (en) 2014-04-21 2019-03-12 Becton Dickinson and Company Limited Vial stabilizer base with connectable vial adapter
ES2792512T3 (es) 2014-04-21 2020-11-11 Becton Dickinson & Co Ltd Dispositivo de trasferencia de fluido y embalaje para el mismo
EP3733147A1 (de) 2014-04-21 2020-11-04 Becton Dickinson and Company Limited Fluidtransfervorrichtung und verpackung dafür
AU2015249872B2 (en) 2014-04-21 2017-01-12 Becton Dickinson and Company Limited Syringe adapter with compound motion disengagement
IL280269B2 (en) 2014-04-21 2024-12-01 Becton Dickinson & Co Ltd Syringe adapter
USD757933S1 (en) 2014-09-11 2016-05-31 Medimop Medical Projects Ltd. Dual vial adapter assemblage
WO2016110838A1 (en) 2015-01-05 2016-07-14 Medimop Medical Projects Ltd Dual vial adapter assemblages with quick release drug vial adapter for ensuring correct usage
BR112018000062B1 (pt) 2015-07-16 2022-05-03 Medimop Medical Projects Ltd Dispositivo de transferência de fármaco líquido para encaixe telescópico flexível seguro em frasco de injeção
USD801522S1 (en) 2015-11-09 2017-10-31 Medimop Medical Projects Ltd. Fluid transfer assembly
EP3380058B1 (de) 2015-11-25 2020-01-08 West Pharma Services IL, Ltd. Dualphiolenadapteranordnung mit arzneimittelphiolenadapter mit selbstverschliessendem zugangsventil
FR3044218B1 (fr) * 2015-11-30 2017-12-29 Biocorp Prod Dispositif de connexion entre un recipient et un contenant, ensemble de connexion comprenant un tel dispositif
IL245800A0 (en) 2016-05-24 2016-08-31 West Pharma Services Il Ltd A device with two vial adapters includes two identical vial adapters
IL245803A0 (en) 2016-05-24 2016-08-31 West Pharma Services Il Ltd Devices with two vial adapters include an aerated drug vial adapter and an aerated liquid vial adapter
IL246073A0 (en) 2016-06-06 2016-08-31 West Pharma Services Il Ltd A fluid transport device for use with a slide-driven piston medicine pump cartridge
IL247376A0 (en) 2016-08-21 2016-12-29 Medimop Medical Projects Ltd Injector assembly
USD832430S1 (en) 2016-11-15 2018-10-30 West Pharma. Services IL, Ltd. Dual vial adapter assemblage
IL249408A0 (en) 2016-12-06 2017-03-30 Medimop Medical Projects Ltd Liquid transfer device for use with infusion liquid container and pincers-like hand tool for use therewith for releasing intact drug vial therefrom
IL251458A0 (en) 2017-03-29 2017-06-29 Medimop Medical Projects Ltd Liquid drug delivery devices are user-operated for use in pre-prepared liquid drug delivery assemblies (rtu)
IL254802A0 (en) 2017-09-29 2017-12-31 Medimop Medical Projects Ltd A device with two vial adapters includes two identical perforated vial adapters
JP7270646B2 (ja) 2018-05-17 2023-05-10 ベクトン ディキンソン フランス 医療用注入装置を容器に接続するためのコネクタ
EP3801437B1 (de) * 2018-05-25 2023-01-04 Becton Dickinson France Verbinder zum verbinden einer medizinischen injektionsvorrichtung mit einem behälter
JP1630477S (de) 2018-07-06 2019-05-07
US20210315775A1 (en) * 2018-09-07 2021-10-14 Becton, Dickinsn And Company Syringe assembly and adapter member
USD923812S1 (en) 2019-01-16 2021-06-29 West Pharma. Services IL, Ltd. Medication mixing apparatus
JP1648075S (de) 2019-01-17 2019-12-16
WO2020148748A1 (en) 2019-01-18 2020-07-23 West Pharma. Services IL, Ltd. Liquid transfer devices for use with intravenous (iv) bottles
EP3917486B1 (de) 2019-01-31 2023-03-08 West Pharma. Services IL, Ltd Flüssigkeitstransfervorrichtung
CN113677382B (zh) 2019-04-09 2023-06-09 西医药服务以色列有限公司 具有集成式注射器的液体输送装置
IL277446B2 (en) 2019-04-30 2024-02-01 West Pharma Services Il Ltd Device for transporting liquids with a double-canal infusion tip
JP2023500782A (ja) 2019-10-08 2023-01-11 ベクトン ディキンソン フランス 医療用注射装置を容器に接続するためのコネクタ、並びにコネクタおよび医療用注射装置を備えるアセンブリ
CN113208916B (zh) * 2020-01-21 2024-12-13 贝克顿·迪金森公司 药瓶适配器装置
US11103641B1 (en) 2020-04-26 2021-08-31 Paul D. Doubet Container adapter for removably attachable syringe
USD956958S1 (en) 2020-07-13 2022-07-05 West Pharma. Services IL, Ltd. Liquid transfer device
CN112027137A (zh) * 2020-08-21 2020-12-04 许敬良 一种液体食品的灌装方法
US20250387300A1 (en) * 2024-06-24 2025-12-25 Becton, Dickinson And Company Closed System Vial Adaptor

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3977555A (en) * 1974-05-07 1976-08-31 Pharmaco, Inc. Protective safety cap for medicament vial
US3940003A (en) * 1974-05-07 1976-02-24 Pharmaco, Inc. Safety cap for medicament vial having puncturable seal
US4589879A (en) * 1983-11-04 1986-05-20 Baxter Travenol Laboratories, Inc. Cannula assembly having closed, pressure-removable piercing tip
IT1173370B (it) * 1984-02-24 1987-06-24 Erba Farmitalia Dispositivo di sicurezza per collegare una siringa alla imboccatura di un flacone contenente un farmaco o di un tubicino per l'erogazione del farmaco della siringa
FR2717086A1 (fr) * 1994-03-11 1995-09-15 Debiotech Dispositif de seringue pour le mélange de deux composés.
CA2170160C (en) * 1993-09-07 2002-08-27 Frederic Neftel Syringe device for mixing two compounds
FR2800713B1 (fr) * 1999-11-05 2002-01-04 Biodome Dispositif de connexion entre un recipient et un contenant et ensemble pret a l'emploi comprenant un tel dispositif
FR2815328B1 (fr) * 2000-10-17 2002-12-20 Biodome Dispositif de connexion entre un recipient et un contenant et ensemble pret a l'emploi comprenant un tel dispositif
US20030105430A1 (en) * 2001-11-30 2003-06-05 Elan Pharma International Limited Wil House Automatic injector
US8454573B2 (en) * 2008-05-06 2013-06-04 Philip Wyatt Medicament administration apparatus
WO2006085327A1 (en) 2005-02-14 2006-08-17 Medimop Medical Projects Ltd Medical device for in situ liquid drug reconstitution in medicinal vessels
US20070060904A1 (en) * 2005-03-14 2007-03-15 Becton, Dickinson And Company Filling system and method for syringes with short needles
WO2008093063A2 (en) * 2007-02-01 2008-08-07 Pa Knowledge Limited Auto injector and adaptor for covering the needle of the auto injector
GB2446778A (en) * 2007-02-01 2008-08-27 Pa Knowledge Ltd Syringe adaptor
US8317743B2 (en) * 2007-09-18 2012-11-27 Medimop Medical Projects Ltd. Medicament mixing and injection apparatus
JP5416529B2 (ja) * 2009-09-29 2014-02-12 テルモ株式会社 薬剤投与具および薬剤容器装着済み薬剤投与具

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2012168235A1 *

Also Published As

Publication number Publication date
CN103619306B (zh) 2016-08-24
JP5981535B2 (ja) 2016-08-31
WO2012168235A1 (fr) 2012-12-13
BR112013031087A2 (pt) 2016-12-06
FR2975896B1 (fr) 2014-06-06
FR2975896A1 (fr) 2012-12-07
CA2837816A1 (fr) 2012-12-13
PL2717827T3 (pl) 2016-01-29
ES2545631T3 (es) 2015-09-14
BR112013031087B1 (pt) 2020-06-16
EP2717827B1 (de) 2015-07-29
AU2012266433A1 (en) 2014-01-09
US20140096862A1 (en) 2014-04-10
PT2717827E (pt) 2015-10-08
CA2837816C (fr) 2018-09-04
JP2014522280A (ja) 2014-09-04
CN103619306A (zh) 2014-03-05
RU2013158253A (ru) 2015-07-20
AU2012266433B2 (en) 2016-05-26
RU2602743C2 (ru) 2016-11-20
US8985162B2 (en) 2015-03-24

Similar Documents

Publication Publication Date Title
EP2717827B1 (de) Vorrichtung zur Verbindung zwischen einem Empfänger und einem Gehäuse und Verfahren zur Montage und Verwendung einer solchen Vorrichtung
EP1226077B1 (de) Einsatzbereite verbindungsvorrichtung
FR2717086A1 (fr) Dispositif de seringue pour le mélange de deux composés.
WO1996014820A1 (fr) Dispositif de seringue fixable sur un flacon
EP2986539B1 (de) Flasche zum verpacken von flüssigkeiten
WO1998013006A1 (fr) Dispositif de connexion, en particulier entre un recipient avec bouchon perforable et une seringue
EP1628695A1 (de) Vorgefüllte spritze mit sicherheitskappe
EP1239808A1 (de) Verbindungsvorrichtung zwischen behälter und inhalt und gebrauchsfertige anordungen die eine solche vorrichtung enthalten
FR2836129A1 (fr) Dispositif de connexion entre un recipient et un contenant et ensemble pret a l'emploi comprenant un tel dispositif
CA2875492A1 (fr) Ensemble d'injection
FR3075056A1 (fr) Dispositif d'injection cryoresistant pret a l'emploi
EP2822870B1 (de) Abdichtungsvorrichtung sowie behälter mit einer solchen vorrichtung
CA2437589A1 (fr) Dispositif de connexion entre un recipient et un contenant et ensemble pret a l'emploi comprenant un tel dispositif
EP3352821B1 (de) Ausgabeanordnung mit einer spritze und einem nadelschutz
EP3383342B1 (de) Vorrichtung zur verbindung eines behälters und behälter und verbindungsanordnung mit solch einer vorrichtung
FR3019804A1 (fr) Flacon de conditionnement de liquide
FR2705898A1 (fr) Dispositif de seringue pour le mélange de deux composés.
FR2715311A1 (fr) Dispositif de seringue pour le mélange de deux composés.
FR2708469A1 (fr) Dispositif de seringue pour le mélange de deux composés.
FR2714294A1 (fr) Dispositif de seringue pour le mélange de deux composés.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20131223

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BIOCORP RECHERCHE ET DEVELOPPEMENT

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20150303

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BIOCORP PRODUCTION

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 738699

Country of ref document: AT

Kind code of ref document: T

Effective date: 20150815

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: FRENCH

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602012009166

Country of ref document: DE

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2545631

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20150914

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: ARNOLD AND SIEDSMA AG, CH

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: PT

Ref legal event code: SC4A

Free format text: AVAILABILITY OF NATIONAL TRANSLATION

Effective date: 20150827

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 738699

Country of ref document: AT

Kind code of ref document: T

Effective date: 20150729

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151030

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151029

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151129

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 5

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602012009166

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20160502

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 6

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20120605

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

REG Reference to a national code

Ref country code: LU

Ref legal event code: HC

Owner name: BIOCORP PRODUCTION S.A.S.; FR

Free format text: FORMER OWNER: BIOCORP PRODUCTION

Effective date: 20250115

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20250228

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20250626

Year of fee payment: 14

Ref country code: PL

Payment date: 20250514

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20250618

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 20250624

Year of fee payment: 14

Ref country code: NL

Payment date: 20250624

Year of fee payment: 14

Ref country code: BE

Payment date: 20250624

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PT

Payment date: 20250515

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20250624

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20250617

Year of fee payment: 14

REG Reference to a national code

Ref country code: NL

Ref legal event code: PD

Owner name: BIOCORP PRODUCTION S.A.S.; FR

Free format text: DETAILS ASSIGNMENT: CHANGE OF OWNER(S), CHANGE OF LEGAL ENTITY; FORMER OWNER NAME: BIOCORP PRODUCTION

Effective date: 20250910

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 602012009166

Country of ref document: DE

Owner name: BIOCORP PRODUCTION, FR

Free format text: FORMER OWNER: BIOCORP PRODUCTION, ISSOIRE, FR

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20250710

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20250623

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20250701

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: MC

Payment date: 20260326

Year of fee payment: 15